References
- Srivastava S. K., Ansari N. H., Hair G. A., Jaspan J., Rao M. B., Das B. Hyperglycaemia-induced activation of human erythrocyte aldose reductase and alterations in kinetic properties. Biochemica et Biophysica Acta 1986; 870: 302–311
- Barnett P. A., Gonzalez R. G., Chylack L. T. The effect of oxidation on sorbitol pathway kinetics. Diabetes 1986; 35: 426–432
- De-Mattia G., Laurenti O., Bravi C., Ghiselli A., Iuliano L., Balsano F. Effect of aldose reductase inhibition on glutathione redox status in erythrocytes of diabetic patients. Metabolism 1994; 43: 965–968
- Jiang Z. Y., Zhou Q. L., Eaton J. W., Koppenol W. H., Hunt J. V., Wolff S. P. Spirohydantion inhibitors of aldose reductase inhibit iron- and copper-catalysed ascorbate oxidation in vitro. Biochemical Pharmcology 1991; 42: 1273–1278
- Wolff S. P., Wang G. M., Spector A. Pro-oxidant activation of ocular reductants. I. Copper and riboflavin stimulate ascorbate oxidation causing lens epithelial cytotoxicity in vitro. Experimental Eye Research 1987; 45: 777–789
- Song H. P., Das B., Srivastava S. K. Micro-determination of aldose and aldehyde reductases from human tissues. Current Eye Research 1987; 6: 1001–1006
- Jiang Z. Y., Woollard A. C. S., Wolff S. P. Lipid hydroperoxide measurement by oxidation of Fe2+ in the presence of xylenol orange. Comparison with the TBA assay and an iodometric method. Lipids 1991; 26: 853–856
- Margoliash E., Novogrodsky A., Schejter A. Irreversible reaction of 3-amino-1.2.4.-triazole and related inhibitors with the protein of catalase. Biochemical Journal 1960; 74: 339–348
- Ou P., Wolff S. P. Aminoguanidine: a drug proposed for prophylaxis in diabetes inhibits catalase and generates hydrogen peroxides in vitro. Biochemical Pharmacology 1993; 46: 1139–1144
- Ou P., Wolff S. P. Erythrocyte catalase inactivation (H2O2) production by ascorbic acid and glucose in the presence of aminotriazole: role of transition metals and relevance to diabetes. Biochemical journal 1994; 303: 935–940
- Hunt J. V., Dean R. T., Wolff S. P. Hydroxyl radical production and autoxidative glycosylation: glucose autoxidation as the cause of protein damage in the experimental glycation model of diabetes mellitus and aging. Biochemical Journal 1988; 256: 243–250
- Kador P. F., Kinoshita J. H., Sharpless N. E. The aldose reductase inhibitor site. Metabolism 1986; 35: 109–113, (No 4, suppl 1)
- Cheng H. M., Gonzalez R. G. The effect of high glucose and oxidative stress on lens metabolism, aldose reductase and senile cataractogenesis. Metabolism 1986; 35: 10–14, (supple 1, April)
- Yeh L. A., Ashton M. A. The increase of lipid peroxidation in rat diabetic lens Can be reversed by oral sorbinil. Metabolism 1990; 39: 619–620
- Wolff S. P., Crabbe M. J. C. Low apparent aldose reductase activity produced by monosaccharide autoxidation. Biochemical Journal 1985; 226: 625–630
- Jeremy Y. J., Kontoghiorges G. J., Hoffbrand A. V., Pandona P. The iron chelators desferoxamine and the l-alkyl-2-methyl-3-hydroxypyrid-4-ones inhibit vascular prostacyclin synthesis in vitro. Biochemical Journal 1988; 254: 239–244